IO
Highly rated in
9
conditions
Highly rated in
9
conditions
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Ifeyinwa N. Osunkwo's experience treating your condition:
About Dr. Ifeyinwa N. Osunkwo

Ifeyinwa Osunkwo is a Pediatrics specialist and a Hematologist Oncology expert in Charlotte, North Carolina. Osunkwo has been practicing medicine for over 29 years and is highly rated in 9 conditions, according to our data. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, Hemoglobinopathy, and Bone Marrow Transplant. She is licensed to treat patients in North Carolina. Osunkwo is currently accepting new patients.

Her clinical research consists of co-authoring 39 peer reviewed articles and participating in 8 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Ifeyinwa N. Osunkwo it is best to call her office and ask if your insurance is accepted.


Dr. Ifeyinwa N. Osunkwo accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  UnitedHealthcare
  •  Aetna

Call to see if your plan is accepted.
Locations
1021 Morehead Medical Dr, Charlotte, NC 28204
Background & Education
Graduate Institution
Other, 1994
Specialties
Pediatrics
Hematology Oncology
Licenses
Pediatrics in NC
Hospital Affiliations
Atrium Health Carolinas Medical Center
Atrium Health University City
Atrium Health Cabarrus
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

A Prospective Phase II, Open-Label, Single-arm, Multicenter, Study to Assess Efficacy and Safety of SEG101 (Crizanlizumab), in Sickle Cell Disease Patients With Priapism (SPARTAN)
Pilot Study of Vitamin D to Ameliorate Chronic Pain in Sickle Cell Disease
A Comparison of Individualized vs. Weight Based Protocols to Treat Vaso-Occlusive Episodes in Sickle Cell Disease
View 6 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors